Myasthenia Gravis: Diagnosis

Overview

Myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular junction. Autoantibodies, most often directed against the acetylcholine receptor (AChR) itself, impair postsynaptic signal transmission. The extraocular muscles and levator palpebrae are unusually sensitive to even small drops in transmission efficiency, so ptosis and diplopia from variable extraocular muscle weakness are often the presenting sign of MG. In a subset of patients, ocular myasthenia gravis, these ocular findings remain the only manifestation for years, sometimes indefinitely.

The clinical feature that should raise suspicion for MG is fatigability and variability: weakness that worsens with sustained use and improves with rest, and a pattern of ptosis or diplopia that shifts from hour to hour or day to day rather than following a fixed cranial nerve distribution. MG can mimic a third nerve palsy, a fourth or sixth nerve palsy, or an internuclear ophthalmoplegia. Pupil involvement is characteristically absent; MG never affects the pupil. For that reason it belongs on the differential for almost any pupil-sparing ocular motility disturbance with a variable course.

Bedside Tests

Several low-cost, low-risk bedside maneuvers rest on a simple fact: neuromuscular transmission in MG can be transiently improved, or worsened, by ordinary physiologic changes. That makes them useful screening tools before serology or electrophysiology results are even back.

Ice Pack Test

An ice pack applied to a ptotic eyelid for about two minutes cools the neuromuscular junction, which reduces acetylcholinesterase enzymatic activity. Acetylcholine that's released then lingers longer, partially compensating for the reduced number of functioning receptors. A measurable improvement in ptosis, classically at least two millimeters, after cooling counts as a positive test. The appeal is practical: no medication, essentially no risk, unlike the edrophonium test below.

Edrophonium (Tensilon) Test

Edrophonium is a short-acting, reversible acetylcholinesterase inhibitor given intravenously. By transiently raising acetylcholine concentration at the neuromuscular junction, it produces a rapid improvement in ptosis or motility in a genuinely myasthenic patient, one that fades just as quickly. Edrophonium can provoke bradycardia and other cholinergic cardiac effects, so the test carries real cardiac risk and should only be performed with atropine immediately available to reverse them. Its use has declined somewhat as antibody testing and single-fiber EMG have become more accessible, but it remains a classic, fast bedside confirmatory test.

Sleep Test & Rest Test

Both tests rest on the same principle as the ice pack test, that reduced muscle use allows transient recovery of neuromuscular transmission, but need no cooling or medication. The sleep test has the patient rest with eyes closed in a dark, quiet room for about thirty minutes; improvement in ptosis or motility immediately on waking supports the diagnosis. The rest test is the same idea compressed into a shorter interval, typically around five minutes of simple eye closure, without sleep or darkness required. Both are useful alternatives when the ice pack test is impractical, for instance in very cold-sensitive skin, or when edrophonium is contraindicated.

Single-Fiber EMG

Single-fiber electromyography is the most sensitive electrophysiologic test for MG. It measures jitter: the variability in the interpotential interval between the action potentials of two muscle fibers belonging to the same motor unit. Neuromuscular transmission in MG is unreliable at the level of an individual fiber, so this timing variability increases, and in more severe cases a fiber may fail to fire altogether ("blocking"). Increased jitter, with or without blocking, is the electrophysiologic hallmark of impaired neuromuscular transmission. It can be positive even in patients with purely ocular disease and negative serology, which is exactly when it earns its keep: clinical suspicion for MG stays high, but the antibody panel came back negative.

Antibody Subtypes

Serologic testing is the most specific diagnostic tool once MG is suspected. The antibody profile itself carries prognostic and phenotypic information:

• Acetylcholine receptor (AChR) antibodies: the most common antibody found in MG overall, detectable even in patients whose disease remains confined to the eyes (ocular MG), though sensitivity is lower in purely ocular disease than in generalized disease.
• Muscle-specific kinase (MuSK) antibodies: target a postsynaptic protein essential for clustering acetylcholine receptors at the neuromuscular junction. MuSK antibodies are strongly associated with generalized, often bulbar-predominant disease and are rarely found in patients whose disease is limited purely to the extraocular and eyelid muscles, which makes a MuSK-positive result somewhat atypical, and prognostically different, in a patient presenting with isolated ocular symptoms.
• Seronegative (AChR- and MuSK-negative) MG: a subset of patients test negative for both principal antibodies; some of these have low-affinity AChR antibodies or other antibodies (e.g., against LRP4) not captured by standard assays. Single-fiber EMG carries real value in this group, since a negative antibody panel doesn't exclude the diagnosis.

Related Topics

Continue exploring Neuro-ophthalmology: